Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Asset disposition
Appointed director
|
|
CTI BIOPHARMA CORP (CTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/12/2011 |
MW
| Cell Therapeutics and Sunesis Eager to Earn Blockbuster Status |
| 03/17/2011 |
MW
| Biotech Merger and Acquisition Activity Looks Poised to Surge |
| 02/17/2011 |
MW
| Cell Therapeutics and Ariad Pharma Face Challenging Approval Processes |
| 02/02/2011 |
MW
| Will Keryx & Cell Therapeutics Remain Healthcare "Winners"? |
| 01/03/2011 |
MW
| Biotech Sector Poised for Growth in 2011 |
| 12/07/2010 |
MW
| Biotech Stocks on the Upswing as FDA Relationships Improve |
| 09/14/2010 |
MW
| Brower Piven Updates Investors Who Acquired Shares of Cell Therapeutics, Inc. Common Stock and Warrants to Purchase Common Stock Through a Public Offering That Commenced on July 22, 2009 of Pending Claims |
| 04/12/2010 |
MW
| Brower Piven Announces the Filing of a Class Action Lawsuit Against Cell Therapeutics, Inc. Expanding the Class Period to Include May 5, 2009 and March 19, 2010 and Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Cell Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 11, 2010 Lead Plaintiff Deadline |
| 03/24/2010 |
MW
| Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Cell Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 11, 2010 Lead Plaintiff Deadline |
| 03/15/2010 |
MW
| Dyer & Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased Cell Therapeutics, Inc. Common Stock Between May 5, 2009 and February 8, 2010; Announces Upcoming Investor Deadline -- CTIC |
| 03/15/2010 |
MW
| Izard Nobel LLP Announces Class Action Lawsuit Against Cell Therapeutics, Inc. |
|
|